Recombinant VEGF (Bevacizumab Biosimilar) antibody
Reactivity: Human
FACS, ELISA, WB, BR, IP
Host: Mouse
Chimeric
unconjugated
Recombinant Antibody
-
- Target See all VEGF (Bevacizumab Biosimilar) products
- VEGF (Bevacizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Chimeric
-
Conjugate
- This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), ELISA, Western Blotting (WB), Blocking Reagent (BR), Immunoprecipitation (IP)
- Characteristics
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Purification
- Purified antibody.
- Immunogen
- Recombinant human VEGF.
- Isotype
- IgG2a kappa
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- VEGF (Bevacizumab Biosimilar)
- Abstract
- VEGF (Bevacizumab Biosimilar) Products
- Synonyms
- MVCD1 antibody, VEGF antibody, VPF antibody, vascular endothelial growth factor A antibody, VEGFA antibody
- Background
- Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
- UniProt
- P15692
-
You are here:
